Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery

SAN FRANCISCO--(BUSINESS WIRE)-- #DNA--Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Twist Biopharma, a division of Twist Bioscience (NASDAQ: TWST), has adopted Genedata Biologics? to support their R&D innovation for biologics drug discovery services. In addition, Twist will use the Genedata platform to enable research in their development of highly sensitive diagnostics and reagents antibodies. "Using our proprietary DNA synthe

Click to view original post